SCNI · CIK 0001611747 · operating
Scinai Immunotherapeutics Ltd. (SCNI) is a biological products, (no diagnostic substances) company incorporated in Israel, listed on the Nasdaq. With a market capitalization of $3 million, Scinai Immunotherapeutics Ltd. is a micro-cap company. The stock currently trades at $0.87, up 3.56% today, with a 52-week range of $0.61–$6.18. The company trades at a trailing P/E of 0.2x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2022 | $-0.01 | $-0.01 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2022-12-31 | 2023-04-17 | 0001213900-23-030228 | SEC ↗ |